Evidence map›Paper›PMID 35860042›Full record

ArticlePeerJ2022

Tumor budding of cervical squamous cell carcinoma: epithelial-mesenchymal transition-like cancer stem cells?

Shaoqiu Zheng, Jing Luo, Shoucheng Xie, Shanming Lu, Qinghua Liu, Huanqin Xiao, Wenjuan Luo, Yanfang Huang, Kun Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shaoqiu ZhengDepartment of Pathology, Meizhou People's Hospital, Meizhou, Guangdong, China.
Jing LuoDepartment of Pelvic Radiotherapy, Meizhou People's Hospital, Meizhou, Guangdong, China.
Shoucheng XieDepartment of Pathology, Meizhou People's Hospital, Meizhou, Guangdong, China.
Shanming LuDepartment of Pathology, Meizhou People's Hospital, Meizhou, Guangdong, China.
Qinghua LiuDepartment of Pathology, Meizhou People's Hospital, Meizhou, Guangdong, China.
Huanqin XiaoDepartment of Pathology, Meizhou People's Hospital, Meizhou, Guangdong, China.
Wenjuan LuoDepartment of Pathology, Meizhou People's Hospital, Meizhou, Guangdong, China.
Yanfang HuangDepartment of Pathology, Meizhou People's Hospital, Meizhou, Guangdong, China.
Kun LiuDepartment of Pathology, Meizhou People's Hospital, Meizhou, Guangdong, China.
Meizhou City People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent evidence indicates that cancer stem cells (CSCs) are the origin of cancers. Scientists have identified CSCs in various tumors and have suggested the existence of a variety of states of CSCs. The existence of epithelial-mesenchymal transition (EMT)-like CSCs has been confirmed

Indexed as

Carcinoma, Squamous CellEpithelial-Mesenchymal TransitionUterine Cervical Neoplasmsbeta CateninCadherinsFemaleHumansKi-67 AntigenNeoplastic Stem CellsVimentinbeta CateninCadherinsKi-67 AntigenVimentinCancer stem cellsCervical squamous cell carcinomaEpithelial–mesenchymal transitionTumor budding

Identifiers

PMID35860042
PMCPMC9291004
OpenAlexW4285591583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.